Verloes R, Atassi G, Dumont P, Kanarek L
Br J Cancer. 1978 Nov;38(5):599-605. doi: 10.1038/bjc.1978.255.
A comparative study of the effects of BCG, Micrococcus lysodeikticus, and a series of structurally related polysaccharides (complement triggers) on the non-specific and specific immune resistance against L1210 lymphoid leukaemia was carried out and commented on. In contrast with authors of earlier reports, we were unable to generate any effective non-specific or specific immunotherapy after the graft of 10(4) leukaemic cells to 8--10-week-old CDF1 mice. However, when mice were prevaccinated with irradiated (8 krad X-rays) cultured cells combined with 1 mg of bacterium or polysaccharide one month before grafting 10(4) cells, they were given an immunoprotection that was more pronounced with the i.p. than with the i.v. route. Prevaccinated mice were afforded a stronger immunoprotection when boosted repeatedly with 1mg injections of bacterium or polysaccharide after tumour challenge.
对卡介苗、溶壁微球菌以及一系列结构相关的多糖(补体激活剂)对抵抗L1210淋巴细胞白血病的非特异性和特异性免疫抵抗力的影响进行了比较研究并作出评论。与早期报告的作者不同,在将10⁴个白血病细胞移植到8 - 10周龄的CDF1小鼠后,我们无法产生任何有效的非特异性或特异性免疫疗法。然而,当小鼠在移植10⁴个细胞前一个月用经辐照(8千拉德X射线)的培养细胞与1毫克细菌或多糖联合进行预先接种时,它们获得了免疫保护,腹腔注射途径比静脉注射途径的免疫保护更明显。在肿瘤攻击后,用1毫克细菌或多糖反复加强注射时,预先接种的小鼠获得了更强的免疫保护。